Literature DB >> 1438193

Hepatitis B virus capsid particles are assembled from core-protein dimer precursors.

S Zhou1, D N Standring.   

Abstract

Our studies on the assembly of hepatitis B virus capsids or core particles in Xenopus oocytes have demonstrated that unassembled p21.5 core proteins ("free p21.5") provide a pool of low-molecular-mass precursors for core-particle assembly. Here we have characterized this material. Free p21.5 sedimented through gradients of 3-25% sucrose (wt/vol) as a single protein species of approximately 40 kDa, corresponding to a p21.5 dimer. On nonreducing SDS/polyacrylamide gels, free p21.5 migrated as disulfide-linked p21.5 dimeric species of 35 and 37 kDa. Truncated core proteins lacking most or all of the 36-amino acid protamine region at the p21.5 carboxyl terminus were also found to behave as disulfide-linked dimers with appropriately reduced molecular masses. Our experiments failed to reveal monomeric core proteins or stable intermediates between dimers and capsids along the assembly pathway. We conclude that hepatitis B virus core particles are most likely assembled by aggregating 90 (or possibly 180) disulfide-linked p21.5 dimers. We discuss similarities between the assembly of hepatitis B virus capsids and simple T = 3 plant virus and bacteriophage structures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438193      PMCID: PMC50274          DOI: 10.1073/pnas.89.21.10046

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Demonstration of hepatitis B e antigen in the core of Dane particles.

Authors:  K Takahashi; Y Akahane; T Gotanda; T Mishiro; M Imai; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

2.  Differential formation of disulfide linkages in the core antigen of extracellular and intracellular hepatitis B virus core particles.

Authors:  K S Jeng; C P Hu; C M Chang
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Characterization of hepatitis B virus capsid particle assembly in Xenopus oocytes.

Authors:  S Zhou; S Q Yang; D N Standring
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

4.  HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells.

Authors:  M A Petit; J Pillot
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein.

Authors:  F Birnbaum; M Nassal
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

6.  Self-assembly of purified polyomavirus capsid protein VP1.

Authors:  D M Salunke; D L Caspar; R L Garcea
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

Review 7.  Icosahedral RNA virus structure.

Authors:  M G Rossmann; J E Johnson
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

8.  Ribonucleoprotein complexes of R17 coat protein and a translational operator analog.

Authors:  D Beckett; O C Uhlenbeck
Journal:  J Mol Biol       Date:  1988-12-20       Impact factor: 5.469

9.  Production of hepatitis B virus nucleocapsidlike core particles in Xenopus oocytes: assembly occurs mainly in the cytoplasm and does not require the nucleus.

Authors:  S L Zhou; D N Standring
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Cys residues of the hepatitis B virus capsid protein are not essential for the assembly of viral core particles but can influence their stability.

Authors:  S Zhou; D N Standring
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more
  56 in total

1.  Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.

Authors:  E V Gazina; J E Fielding; B Lin; D A Anderson
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids?

Authors:  M I Barrasa; J T Guo; J Saputelli; W S Mason; C Seeger
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Effects of mutations within and adjacent to the terminal repeats of hepatitis B virus pregenomic RNA on viral DNA synthesis.

Authors:  S Perri; D Ganem
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  A reaction landscape identifies the intermediates critical for self-assembly of virus capsids and other polyhedral structures.

Authors:  Dan Endres; Masaki Miyahara; Paul Moisant; Adam Zlotnick
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

Review 5.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

6.  In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions).

Authors:  Adam Zlotnick; Angela Lee; Christina R Bourne; Jennifer M Johnson; Paul L Domanico; Stephen J Stray
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 7.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 8.  Hepatitis B virus morphogenesis.

Authors:  Volker Bruss
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

9.  Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus.

Authors:  M Kann; W H Gerlich
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1.

Authors:  M Seifer; D N Standring
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.